FindTrial
Sign In

A Study to Understand How Cancer Treatment Affects Heart Function in Children

Assessment of change in myocardial deformation parameters in pediatric cancer patients receiving anthracycline-based chemotherapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084865
Enrollment
60
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C933- Juvenile myelomonocytic leukemia

Interventions

Intervention1: NIL: NIL

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) All pediatric patients having cancer planned for anthracycline based chemotherapy with normal LA & LV function at baseline

Exclusion criteria

Exclusion criteria: 1) Children with previously diagnosed cardiac disease. 2) Childhood cancer survivors 3) Subjects undergoing radiotherapy 4) Seriously ill children, with life expectancy of less than 1 year 5) Patients with other serious comorbidities

Design outcomes

Primary

MeasureTime frame
1) LV systolic function assessment 2) RV function assessmentTimepoint: 1) At the recruitment 2) At three months 3) At six months—

Secondary

MeasureTime frame
NILTimepoint: NA—

Countries

India

Contacts

Public ContactDr Jyothi Samanth

Manipal College of Health Profession

samanth.jyothi@manipal.edu9964586823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026